Search Results - "Shinada, Mitsuhiro"

64 Cu 2+ Complexes of Tripodal Amine Ligands' In Vivo Tumor and Liver Uptakes and Intracellular Cu Distribution in the Extrahepatic Bile Duct Carcinoma Cell Line TFK-1: A Basic Comparative Study.

Authors: Shinada, Mitsuhiro Takahashi, Masashi Igarashi, Chika et al.

Source: Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p820. 12p.

Trace Metal Impurities Effects on the Formation of [ 64 Cu]Cu-diacetyl-bis(N 4 -methylthiosemicarbazone) ([ 64 Cu]Cu-ATSM).

Authors: Shinada, Mitsuhiro Suzuki, Hisashi Hanyu, Masayuki et al.

Source: Pharmaceuticals (14248247). Jan2024, Vol. 17 Issue 1, p10. 12p.

An In Vivo Dual-Observation Method to Monitor Tumor Mass and Tumor-Surface Blood Vessels for Developing Anti-Angiogenesis Agents against Submillimeter Tumors.

Authors: Tachibana, Tomoko Oyama, Tomoko Gowa Yoshii, Yukie et al.

Source: International Journal of Molecular Sciences. Dec2023, Vol. 24 Issue 24, p17234. 15p.

Process to Remove the Size Variants Contained in the Antibody–Chelator Complex PCTA-NCAB001 for Radiolabeling with Copper-64.

Authors: Yoshii, Yukie Matsumoto, Hiroki Igarashi, Chika et al.

Source: Pharmaceuticals (14248247). Oct2023, Vol. 16 Issue 10, p1341. 12p.

Preclinical Safety Evaluation of Intraperitoneally Administered Cu-Conjugated Anti-EGFR Antibody NCAB001 for the Early Diagnosis of Pancreatic Cancer Using PET.

Authors: Matsumoto, Hiroki Igarashi, Chika Tachibana, Tomoko et al.

Source: Pharmaceutics. Sep2022, Vol. 14 Issue 9, pN.PAG-N.PAG. 15p.

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64 Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study.

Authors: Hihara, Fukiko Matsumoto, Hiroki Yoshimoto, Mitsuyoshi et al.

Source: International Journal of Molecular Sciences. May2022, Vol. 23 Issue 10, p5807-5807. 15p.

Local therapy with hypoxia-targeting radiopharmaceutical [64Cu]Cu-ATSM in high-grade glioma patient-derived xenograft models.

Authors: Yoshii, Yukie Hihara, Fukiko Matsumoto, Hiroki et al.

Source: Radiotherapy & Oncology. Jan2026, Vol. 214, pN.PAG-N.PAG. 1p.

Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225 Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.

Authors: Yoshimoto, Mitsuyoshi Yoshii, Yukie Matsumoto, Hiroki et al.

Source: Pharmaceutics. Oct2021, Vol. 13 Issue 10, p1706-1706. 1p.